Consensus statements have been developed for screening, diagnosis, and treatment of rheumatoid arthritis-associated interstitial lung disease.

People living with interstitial lung disease (ILD) are especially vulnerable during extreme heat. As climate change drives more frequent and intense heatwaves, people with ILD will need better ...

Investors seeking to preserve capital in a volatile environment might consider large-cap stocks such as Iliad SA (ENXTPA:ILD) a safer option. One reason being its ‘too big to fail’ aura which gives it ...

Structured follow-up and proactive management of adverse events are key factors associated with antifibrotic persistence in patients with ILD.

The prevalence of interstitial lung disease (ILD) across connective tissue disorders (CTDs) and its persistent standing as a leading cause of death in patients with CTDs challenge rheumatologists to ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Alicia M. Hinze, MD: Some of the unmet needs that we have in interstitial lung disease [ILD] in the context of scleroderma would be, what do we do if patients continue to progress on our ...

Nintedanib offered no significant advantage over placebo in patients with interstitial lung disease (ILD) following a severe SARS-CoV-2 infection. No significant differences were observed between ...

Neil B. Minkoff, MD: Dr Hummers, please share the prevalence of chronic fibrosis ILD [interstitial lung disease] with the progressive phenotype? Laura Hummers, MD: It’s tricky to determine a phenotype ...

Nintedanib appears to stabilize lung function in patients with systemic sclerosis-associated ILD exhibiting a PPF phenotype.

Diffuse parenchymal lung diseases encompass a large number of conditions, with a wide range of causes, clinical manifestations, and imaging and pathological features, as well as variable outcomes.